Added to YB: 2026-07-31
Pitch date: 2026-07-29
SEER [neutral]
Seer, Inc.
-0.48%
current return
Author Info
Triple S is a professional special situations investor who shares ideas in their newsletter. Sign up for the newsletter.
Company Info
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.
Market Cap
$114.4M
Pitch Price
$2.07
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.42
P/E
-1.67
EV/Sales
-1.93
Sector
Life Sciences Tools and Services
Category
special_situation
Seer, Inc. - $SEER
SEER (update): Trades $2.04 vs ~$3.90 net cash/shr, no debt, -$105M EV. 5 buyout bids since April all rejected, incl CEO's own $2.45+CVR. Flat $16M rev 4yrs, ~$60M/yr burn, breakeven 2031. All 3 proxy advisors backed activist Radoff; 4.9% pill on ballot. But board swept vote today — new $2.55+CVR offer pending. Bear: sub-$1.50 by Xmas if board wins.
Read full article (6 min)